Jong Lee, Day Zero CEO (via Day Zero website)

Ge­nomics + ma­chine learn­ing = com­pa­ny's strat­e­gy to speed up hos­pi­tal di­ag­nos­tics and iden­ti­fy an­tibi­ot­ic re­sis­tance

Day Ze­ro Di­ag­nos­tics has been fo­cused on com­bin­ing genome se­quenc­ing and ma­chine learn­ing to di­ag­nose in­fec­tious dis­eases. And now the di­ag­nos­tics play­er has net­ted its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.